New PD-L1 inhibitors in non-small cell lung cancer – impact of atezolizumab

Autor: Seetharamu N, Preeshagul IR, Sullivan KM

Publikováno v: Lung Cancer: Targets and Therapy, Vol Volume 8, Pp 67-78 (2017)

Nagashree Seetharamu, Isabel R Preeshagul, Kevin M Sullivan Monter Cancer Center, Hofstra-Northwell Health School of Medicine, Lake Success, NY, USA Abstract: The era of immunotherapy has changed the face of how we approach treatment for many oncolog

Externí odkaz: https://doaj.org/article/8a0a5dfc63c14e2b808511bcd61aa5dd

Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas.

Autor: Elkrief A; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Makhnin A; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Moses KA; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Ahn LS; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Preeshagul IR; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Iqbal AN; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Hayes SA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Paik PK; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York., Ladanyi M; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Kris MG; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., Riely GJ; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York., Michor F; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, Massachusetts.; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, Massachusetts.; Center for Cancer Evolution, Dana-Farber Cancer Institute, Boston, Massachusetts.; The Broad Institute of Harvard and MIT, Cambridge, Massachusetts.; The Ludwig Center at Harvard, Boston, Massachusetts., Yu HA; Department of Medicine, Thoracic Oncology Service, Division of Solid Tumor Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.; Department of Medicine, Weill Cornell Medical College, New York, New York.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Apr 14; Vol. 29 (8), pp. 1423-1428.

Optimizing adjuvant therapy in EGFR -mutated non-small cell lung cancer.

Autor: Shepherd AF; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, New York Proton Center, New York, NY, USA., Preeshagul IR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Shaverdian N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Wu AJ; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gelblum DY; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Gomez DR; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Rimner A; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Simone CB 2nd; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, New York Proton Center, New York, NY, USA.

Publikováno v: Annals of translational medicine [Ann Transl Med] 2020 Dec; Vol. 8 (23), pp. 1613.

Evaluating of HPV-DNA ISH as an adjunct to p16 testing in oropharyngeal cancer.

Autor: Chi J; Department of Medical Oncology/Hematology, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Preeshagul IR; Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Sheikh-Fayyaz S; Department of Pathology, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Teckie S; Department of Radiation Medicine, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Kohn N; Department of Biostatistics, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11030, USA., Ziemba Y; Department of Pathology, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Laser A; Department of Pathology, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Frank D; Department of Otolaryngology - Head & Neck Surgery, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Ghaly M; Department of Pathology, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Kamdar D; Department of Otolaryngology - Head & Neck Surgery, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Kraus D; Department of Otolaryngology - Head & Neck Surgery, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Paul D; Department of Medical Oncology/Hematology, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA., Seetharamu N; Department of Medical Oncology/Hematology, Donald & Barbara Zucker School of Medicine at Hofstra/Northwell, New York, NY 11042, USA.

Publikováno v: Future science OA [Future Sci OA] 2020 Aug 03; Vol. 6 (9), pp. FSO606. Date of Electronic Publication: 2020 Aug 03.

Circulating Tumor DNA Analysis to Assess Risk of Progression after Long-term Response to PD-(L)1 Blockade in NSCLC.

Autor: Hellmann MD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. diehn@stanford.edu arasha@stanford.edu hellmanm@mskcc.org.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York.; Parker Center for Cancer Immunotherapy, San Francisco, California., Nabet BY; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Rizvi H; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Chaudhuri AA; Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Wells DK; Parker Center for Cancer Immunotherapy, San Francisco, California., Dunphy MPS; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Chabon JJ; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Liu CL; Stanford Cancer Institute, Stanford University, Stanford, California.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Hui AB; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Arbour KC; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Luo J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Preeshagul IR; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York., Moding EJ; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Almanza D; Department of Radiation Oncology, Stanford University, Stanford, California.; Stanford Cancer Institute, Stanford University, Stanford, California., Bonilla RF; Department of Radiation Oncology, Stanford University, Stanford, California., Sauter JL; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York., Choi H; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York., Tenet M; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Abu-Akeel M; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York., Plodkowski AJ; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Perez Johnston R; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York., Yoo CH; Department of Radiation Oncology, Stanford University, Stanford, California., Ko RB; Department of Radiation Oncology, Stanford University, Stanford, California., Stehr H; Department of Pathology, Stanford University, Stanford, California., Gojenola L; Department of Pathology, Stanford University, Stanford, California., Wakelee HA; Stanford Cancer Institute, Stanford University, Stanford, California.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Padda SK; Stanford Cancer Institute, Stanford University, Stanford, California.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Neal JW; Stanford Cancer Institute, Stanford University, Stanford, California.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Chaft JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Kris MG; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Rudin CM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Merghoub T; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Parker Center for Cancer Immunotherapy, San Francisco, California.; Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, New York., Li BT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.; Weill Cornell School of Medicine, New York, New York.; Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, New York., Alizadeh AA; Stanford Cancer Institute, Stanford University, Stanford, California. diehn@stanford.edu arasha@stanford.edu hellmanm@mskcc.org.; Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University, Stanford, California., Diehn M; Department of Radiation Oncology, Stanford University, Stanford, California. diehn@stanford.edu arasha@stanford.edu hellmanm@mskcc.org.; Stanford Cancer Institute, Stanford University, Stanford, California.; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, California.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jun 15; Vol. 26 (12), pp. 2849-2858. Date of Electronic Publication: 2020 Feb 11.